Evaluation of tumor hypoxia prior to radiotherapy in intermediate-risk prostate cancer using (18)F-fluoromisonidazole PET/CT: a pilot study

PURPOSE: Hypoxia is a major factor in prostate cancer aggressiveness and radioresistance. Predicting which patients might be bad candidates for radiotherapy may help better personalize treatment decisions in intermediate-risk prostate cancer patients. We assessed spatial distribution of (18)F-Misoni...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Oncotarget
Autors principals: Supiot, Stéphane, Rousseau, Caroline, Dore, Mélanie, Cheze-Le-Rest, Catherine, Kandel-Aznar, Christine, Potiron, Vincent, Guerif, Stéphane, Paris, François, Ferrer, Ludovic, Campion, Loïc, Meingan, Philippe, Delpon, Gregory, Hatt, Mathieu, Visvikis, Dimitris
Format: Artigo
Idioma:Inglês
Publicat: Impact Journals LLC 2018
Matèries:
Research Paper
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5839367/
https://ncbi.nlm.nih.gov/pubmed/29515786
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.24234
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars